GLOBAL’s Position Statement on Humanitarian Crisis in Ukraine
March 29th, 2022 by Global Down Syndrome Foundation
Global Down Syndrome Foundation has been following the developments and grave humanitarian crisis taking place in Ukraine. We are all deeply concerned for the men, women, children, elderly, and people with disabilities who are being forced to leave their homes due to the conflict and those who are still trying to escape Ukraine to neighboring countries.
In dangerous and confusing times such as these, people with disabilities are often overlooked and face greater risk of abandonment, violence, and even death. There are food and medication shortages, and people with disabilities are cut off from support services. The situation is dire.
GLOBAL is adding our voice to international efforts, alongside other Down syndrome and disability organizations from around the world, asking that the parties and governments involved in the conflict respect humanitarian and international rights laws, and we ask that Ukrainians with Down syndrome and other disabilities be prioritized for evacuation and humanitarian aid.
National Coverage Determination May Limit Access to AD Treatment
March 14th, 2022 by Global Down Syndrome Foundation
National Coverage Determination May Limit Access to AD Treatment
HealthPayerIntelligence | Mar 14, 2022
Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers
February 23rd, 2022 by Global Down Syndrome Foundation
Medicare Proposal on Alzheimer’s Drug Draws Criticism From Drugmakers
The Wall Street Journal | Feb 23, 2022
Alzheimer’s patients ‘devastated’ at Medicare limits on drug critics say needs more testing
February 18th, 2022 by Wes Butler
Alzheimer’s patients ‘devastated’ at Medicare limits on drug critics say needs more testing
USA Today | Feb 18, 2022
How The Medical System Is Failing People With Down Syndrome And Alzheimer’s Disease
February 10th, 2022 by Wes Butler
How The Medical System Is Failing People With Down Syndrome And Alzheimer’s Disease
Forbes | Feb 10, 2022
CMS severely limits coverage of Alzheimer’s treatment: What it means for people living with the disease
January 24th, 2022 by Wes Butler
CMS severely limits coverage of Alzheimer’s treatment: What it means for people living with the disease
WFMY News 2 | Jan 24, 2022
Biogen Alzheimer’s Drug Coverage Threatens Minorities’ Access
January 13th, 2022 by Global Down Syndrome Foundation
Biogen Alzheimer’s Drug Coverage Threatens Minorities’ Access
Bloomberg Law | Jan 13, 2022
Medicare limits coverage of $28,000-a-year Alzheimer’s drug
January 12th, 2022 by Global Down Syndrome Foundation
Medicare limits coverage of $28,000-a-year Alzheimer’s drug
FOX 59 | Jan 12, 2022
Alzheimer’s groups vow to fight proposed Medicare restrictions on controversial drug
January 12th, 2022 by Global Down Syndrome Foundation
Alzheimer’s groups vow to fight proposed Medicare restrictions on controversial drug
The Washington Post | Jan 12, 2022
Medicare proposes limited coverage of controversial Alzheimer’s drug
January 11th, 2022 by Global Down Syndrome Foundation
Medicare proposes limited coverage of controversial Alzheimer’s drug
The Hill | Jan 11, 2022
Experience our inspirational and groundbreaking videos and photos. Our children and self-advocates are beautiful AND brilliant!
Make sure your local Representatives are on the Congressional Down Syndrome Task Force.
Find us online here: